JESSICA THOMAS: Open Payments
NPI 1205596947 · GERRY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 48 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $240 · 2025 $1,701
Food & beverage: $1,643Education: $58
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $697 |
| Regeneron Healthcare Solutions, Inc. | 11 | $527 |
| Novartis Pharmaceuticals Corporation | 9 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $86 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $63 |
| Cycle Pharmaceuticals Inc | 2 | $44 |
| Optinose US, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, TEZSPIRE, CUVITRU, NEFFY, Rhapsido, Sajazir.
Industry payments across NY — which companies pay providers there.
